1-1 of 1
Ibou Dieye
Close
Sort by
Journal Articles

Cost-Effectiveness of Polatuzumab Vedotin Plus Bendamustine-Rituximab for Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States

Keith A Betts, Federico Felizzi, Ibou Dieye, Jia Li, Mathias Schulz, Samuel J Hong, Anthony S Masaquel
Journal: Blood
Blood (2020) 136 (Supplement 1): 3.
https://doi.org/10.1182/blood-2020-136273
Published: 2020